Assessing external cephalic version for breech presentation in twin pregnancies
Twin A Breech External Cephalic Version Intervention Trial
This study is testing if a special technique called external cephalic version can help turn breech babies in twin pregnancies to see if it works better than what we currently know.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 45 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | Charite University, Berlin, Germany Academic / other |
| Locations | 1 site (Mitte) |
| Trial ID | NCT04579835 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on the management of Twin A breech presentation in twin pregnancies through the use of external cephalic version (ECV). It aims to evaluate the success rate of ECV in an obstetric clinic and to identify new sonographic criteria that may predict successful outcomes, which have not been previously explored. The study will involve consenting patients over the age of 18 who meet specific eligibility criteria, while excluding those with certain complications. Data will be collected to enhance understanding of ECV effectiveness in this unique patient population.
Who should consider this trial
Good fit: Ideal candidates for this study are pregnant women over 18 years old with a Twin A breech presentation who can provide informed consent.
Not a fit: Patients with conditions such as placenta previa or fetal abnormalities may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve the management of breech presentations in twin pregnancies, potentially leading to safer delivery options.
How similar studies have performed: While there have been studies on external cephalic version, this specific approach focusing on Twin A breech presentation is novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Presence of the written consent of the patients. * The patients must be over 18 years old . * No limit in the ability to consent. Exclusion Criteria: * Age under 18 * Limited ability to consent * Placenta previa * Fetal abnormalities
Where this trial is running
Mitte
- Charité University Hospital — Mitte, Germany (Recruiting)
Study contacts
- Principal investigator: Larry Hinkson, FRCOG — Charité University Hospital
- Study coordinator: Larry Hinkson, FRCOG
- Email: Larry.Hinkson@charite.de
- Phone: 004930450664710
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.